Last deal

$15.7M
Local Amount - CNY 100.M

Amount

Series A

Stage

30.12.2021

Date

2

all rounds

$16.4M

Total amount

General

About Company
Wancheng Gene is a single-cell gene detection platform serving scientific, clinical, and industrial markets.

Industry

Sector :

Subsector :

Also Known As

万乘基因

founded date

01.01.2018

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company offers a range of services including sample preparation, sequencing, analysis, and processing, which can be customized based on customer needs. They specialize in T cell receptor repertoire sequencing for therapeutics, diagnostics, and treatment monitoring. Additionally, they provide single-cell multi-omics technology for research and industrial-grade production. Their proprietary products and services include a bioinformatics platform for high throughput single-cell analysis, as well as low throughput single-cell transcriptome sequencing, single-cell immune sequencing, and ATAC-sequencing. Wancheng Gene aims to provide professional and reliable geno-sequencing solutions for major pharmaceutical commercialization.
Contacts